Effect of Magnesium Sulphate on Serum lactate in living donor hepatectomy.

Effect of Intraoperative magnesium sulphate intravenous infusion on serum lactate levels in living donor hepatectomy.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202501699964568

Enrollment

Registered

2025-01-22

Start date

2024-12-28

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia

Interventions

Magnesium Sulphate

Normal Saline

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: • Age group 18 – 40. • Either sex. • ASA 1 or 2. • Undergoing elective donor right hepatectomy.

Exclusion criteria

Exclusion criteria: • Refusal to participate. • History of allergy or contraindication to Mg. • Regular Mg intake. • Emergency donor hepatectomy. • Left hepatectomy.

Design outcomes

Primary

Measure	Time frame
Serum lactate level	—

Secondary

Measure	Time frame
Arterial pH, base excess, ALT and AST.	—

Countries

Egypt

Contacts

Public ContactDouaa Ibrahim

Faculty of Medicine Ain Shams University

douaa.galal@med.asu.edu.eg+201006155597

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026